PCN95 COST-EFFECTIVENESS ANALYSIS OF GERMLINE BRCA MUTATION TESTING AND OLAPARIB TREATMENT IN METASTATIC BREAST CANCER: AN EVALUATION OF CODEPENDENT TECHNOLOGIES
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.292
https://www.valueinhealthjournal.com/article/S1098-3015(19)32670-1/fulltext
Title :
PCN95 COST-EFFECTIVENESS ANALYSIS OF GERMLINE BRCA MUTATION TESTING AND OLAPARIB TREATMENT IN METASTATIC BREAST CANCER: AN EVALUATION OF CODEPENDENT TECHNOLOGIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32670-1&doi=10.1016/j.jval.2019.09.292
First page :
Section Title :
Open access? :
No
Section Order :
10233